0
0
Read Time:10 Second
Nectar Lifesciences Limited has informed the Exchange regarding a press release dated July 08, 2025, titled “Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
